TY  - JOUR 
AU  - Terpos, Evangelos
AU  - Sezer, O.
AU  - Croucher, P.I.
AU  - García Sanz, Ramón
AU  - Boccadoro, M.
AU  - San Miguel Izquierdo, Jesús Fernando
AU  - Ashcroft, J.
AU  - Bladé, Joan
AU  - Cavo, M.
AU  - Delforge, M.
AU  - Dimopoulos, Meletios A.
AU  - Facon, T.
AU  - Macro, M.
AU  - Waage, A.
AU  - Sonneveld, P.
PY  - 2009
SN  - 0923-7534
UR  - http://hdl.handle.net/10366/155256
AB  - [EN]Bisphosphonates (BPs) prevent, reduce, and delay multiple myeloma (MM)-related skeletal complications. Intravenous pamidronate and zoledronic acid, and oral clodronate are used for the management of MM bone disease. The purpose of this paper is to...
LA  - eng
PB  - Elsevier
KW  - Myeloma
KW  - Bone Disease
KW  - International consensus
KW  - Expert recommendations
KW  - Diphosphonates
KW  - Multiple Myeloma
KW  - Bone Neoplasms
KW  - Humans
TI  - The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
DO  - 10.1093/annonc/mdn796
T2  - Annals of Oncology
VL  - 20
M2  - 1303
ER  -